跳至主要内容
临床试验/NCT03269214
NCT03269214已完成不适用

Does Topical Phenytoin Enhance Healing Process in Bisphosphonate-related Osteonecrosis of the Mandible. A Uni-blind Clinical Trial Study

Shiraz University of Medical Sciences0 个研究点目标入组 20 人开始时间: 2012年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
20
主要终点
Soft tissue healing

研究概览

简要总结

Patients who had bisphosphonate-related osteonecrosis of the jaw in stage II were allocated in two groups randomly : In group1, 10 patients underwent debridement and primary closer of the area,in group 2 , patients received Phenytoin + tetracycline topically in the debridement area.Wound dehiscence , infection and pain were in 1,6 and 12 months after treatment.

详细描述

All patients undergo surgical necrotic bone debridement in combination with antibiotic therapy (clindamycin 300 mg q8h) for 4 weeks . Patients who had BRON of the mandible randomly allocated in 2 groups. Group 1 underwent debridement of necrotic bone and the involved area closed primary and in group 2 ,patients received topical Phenytoin 5%+ Tetracycline. Patients were evaluated after 1(time1) ,6(time2) and 12(time 3) months.

The size of bone lesion was measured by using come beam computer tomography (CBCT).

Wound dehiscence (Stage 0 :No dehiscence ,Stage 1: less than 10 mm dehiscence,stage 2 : more than 10 mm dehiscence) Infection: Pus, sinus tract (Yes/NO) Pain according to visual analog scale (VAS) 0-10.In the third follow up time ( 12 months) ,the number of patients who were a time span of 3 months without clinical symptoms were documented in each group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

盲法说明

Neither patients nor investigators were unaware about treatment and control groups.

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Criteria of bisphosphonate-related Osteonecrosis in stage II
  • need debridement and surgical intervention

排除标准

  • Malignancy in the area
  • History of chemotherapy ,
  • diabetic mellitus
  • odontogenic infection or undergo dialysis

研究组 & 干预措施

treatment group

Experimental

Patients received topical Phenytoin 5%+ Tetracycline after debridement before final closure.

干预措施: Topical Phenytoin 5% (Drug)

结局指标

主要结局

Soft tissue healing

时间窗: 12 months after treatment

Appropriate soft tissue healing was defined when no dehiscence occurred

Pain

时间窗: Six months after treatment

Based on visual analogue scale 0-10

次要结局

  • Infection(12 months after treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Reza Tabrizi

associate professor of oral and maxillofacial surgery

Shiraz University of Medical Sciences

相似试验

Use of Topical Phenytoin in Bisphosphonate-related... | 临床试验